Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05219513 |
|---|---|
| Brief Title: | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7443904 in Combination With Glofitamab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma |
| First Submitted : | November 23, 2021 |
| First Submitted that Met QC Criteria : | January 20, 2022 |
| First Posted : | February 2, 2022 |
| Last Update Submitted that Met QC Criteria : | March 16, 2023 |
| Last Update Posted : | March 20, 2023 |